H.R. 6702 · 117th Congress
Safeguarding Women’s and Children’s Health Act of 2022
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
WalorskiSponsor31 cosponsors · 31 R
R
Burgess
BB
R
Babin
JB
R
Banks
TB
R
Burchett
JC
R
Curtis
JD
R
Duncan
JE
R
Ellzey
RF
R
Feenstra
VF
R
Foxx
MF
R
Fischbach
CF
R
Franklin
RH
R
Hudson
JJ
R
Joyce
DL
R
Lamborn
BL
R
Luetkemeyer
BL
R
Long
DL
R
LaMalfa
DM
R
McKinley
AM
R
Mooney
MM
R
Miller-Meeks
LB
R
Bucshon
DL
R
LaHood
ES
R
Stefanik
CT
R
Tenney
BW
R
Wenstrup
JB
R
Baird
TE
R
Emmer
GG
R
Grothman
BD
R
Donalds
LM
R
McClain
BM
R
Moore20 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill imposes reporting requirements relating to abortion drugs.
What it does: CRS summary · Introduced in House · Feb 9, 2022
Safeguarding Women's and Children's Health Act of 2022
This bill imposes reporting requirements relating to abortion drugs.
The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug.
The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events.
The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Safeguarding Women’s and Children’s Health Act of 2022
Latest action (Feb 10, 2022): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Feb 9, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.